274 related articles for article (PubMed ID: 17108116)
21. Nonsupervised construction and application of mass spectral and retention time index libraries from time-of-flight gas chromatography-mass spectrometry metabolite profiles.
Erban A; Schauer N; Fernie AR; Kopka J
Methods Mol Biol; 2007; 358():19-38. PubMed ID: 17035678
[TBL] [Abstract][Full Text] [Related]
22. Global metabolic profiling of Escherichia coli cultures: an evaluation of methods for quenching and extraction of intracellular metabolites.
Winder CL; Dunn WB; Schuler S; Broadhurst D; Jarvis R; Stephens GM; Goodacre R
Anal Chem; 2008 Apr; 80(8):2939-48. PubMed ID: 18331064
[TBL] [Abstract][Full Text] [Related]
23. A metabolomic analysis of the toxicity of Aconitum sp. alkaloids in rats using gas chromatography/mass spectrometry.
Sun B; Wu S; Li L; Li H; Zhang Q; Chen H; Li F; Dong F; Yan X
Rapid Commun Mass Spectrom; 2009 Apr; 23(8):1221-8. PubMed ID: 19283786
[TBL] [Abstract][Full Text] [Related]
24. Development and optimization of a metabolomic method for analysis of adherent cell cultures.
Danielsson AP; Moritz T; Mulder H; Spégel P
Anal Biochem; 2010 Sep; 404(1):30-9. PubMed ID: 20417172
[TBL] [Abstract][Full Text] [Related]
25. Use of gene expression profiles to stage concurrent endometrioid tumors of the endometrium and ovary.
Guirguis A; Elishaev E; Oh SH; Tseng GC; Zorn K; DeLoia JA
Gynecol Oncol; 2008 Feb; 108(2):370-6. PubMed ID: 18083218
[TBL] [Abstract][Full Text] [Related]
26. Application of dissimilarity indices, principal coordinates analysis, and rank tests to peak tables in metabolomics of the gas chromatography/mass spectrometry of human sweat.
Xu Y; Gong F; Dixon SJ; Brereton RG; Soini HA; Novotny MV; Oberzaucher E; Grammer K; Penn DJ
Anal Chem; 2007 Aug; 79(15):5633-41. PubMed ID: 17602669
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for benign, borderline and invasive mucinous ovarian tumors: epidemiological evidence of a neoplastic continuum?
Jordan SJ; Green AC; Whiteman DC; Webb PM;
Gynecol Oncol; 2007 Nov; 107(2):223-30. PubMed ID: 17662378
[TBL] [Abstract][Full Text] [Related]
28. Development and validation of a gas chromatography/mass spectrometry metabonomic platform for the global profiling of urinary metabolites.
Pasikanti KK; Ho PC; Chan EC
Rapid Commun Mass Spectrom; 2008 Oct; 22(19):2984-92. PubMed ID: 18763274
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous and exact interval estimates for the contrast of two groups based on an extremely high dimensional variable: application to mass spec data.
Park Y; Downing SR; Kim D; Hahn WC; Li C; Kantoff PW; Wei LJ
Bioinformatics; 2007 Jun; 23(12):1451-8. PubMed ID: 17459967
[TBL] [Abstract][Full Text] [Related]
30. Independent component analysis in non-hypothesis driven metabolomics: improvement of pattern discovery and simplification of biological data interpretation demonstrated with plasma samples of exercising humans.
Li X; Hansen J; Zhao X; Lu X; Weigert C; Häring HU; Pedersen BK; Plomgaard P; Lehmann R; Xu G
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Dec; 910():156-62. PubMed ID: 22809791
[TBL] [Abstract][Full Text] [Related]
31. Efficient mining of myxobacterial metabolite profiles enabled by liquid chromatography-electrospray ionisation-time-of-flight mass spectrometry and compound-based principal component analysis.
Krug D; Zurek G; Schneider B; Garcia R; Müller R
Anal Chim Acta; 2008 Aug; 624(1):97-106. PubMed ID: 18706314
[TBL] [Abstract][Full Text] [Related]
32. Study of plasma metabolic profiling and biomarkers of chronic unpredictable mild stress rats based on gas chromatography/mass spectrometry.
Li ZY; Zheng XY; Gao XX; Zhou YZ; Sun HF; Zhang LZ; Guo XQ; Du GH; Qin XM
Rapid Commun Mass Spectrom; 2010 Dec; 24(24):3539-46. PubMed ID: 21080506
[TBL] [Abstract][Full Text] [Related]
33. Metabolite profiling of mycorrhizal roots of Medicago truncatula.
Schliemann W; Ammer C; Strack D
Phytochemistry; 2008 Jan; 69(1):112-46. PubMed ID: 17706732
[TBL] [Abstract][Full Text] [Related]
34. Systematic identification of conserved metabolites in GC/MS data for metabolomics and biomarker discovery.
Styczynski MP; Moxley JF; Tong LV; Walther JL; Jensen KL; Stephanopoulos GN
Anal Chem; 2007 Feb; 79(3):966-73. PubMed ID: 17263323
[TBL] [Abstract][Full Text] [Related]
35. Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas.
Cuatrecasas M; Catasus L; Palacios J; Prat J
Am J Surg Pathol; 2009 Apr; 33(4):556-67. PubMed ID: 19033864
[TBL] [Abstract][Full Text] [Related]
36. Gas chromatography/mass spectrometry in metabolic profiling of biological fluids.
Pasikanti KK; Ho PC; Chan EC
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Aug; 871(2):202-11. PubMed ID: 18479983
[TBL] [Abstract][Full Text] [Related]
37. Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma.
Yang GF; Xie D; Liu JH; Luo JH; Li LJ; Hua WF; Wu HM; Kung HF; Zeng YX; Guan XY
Gynecol Oncol; 2009 Feb; 112(2):314-8. PubMed ID: 19054548
[TBL] [Abstract][Full Text] [Related]
38. Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS.
Qiu Y; Cai G; Su M; Chen T; Zheng X; Xu Y; Ni Y; Zhao A; Xu LX; Cai S; Jia W
J Proteome Res; 2009 Oct; 8(10):4844-50. PubMed ID: 19678709
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of mammaglobin B in epithelial ovarian carcinomas.
Tassi RA; Bignotti E; Rossi E; Falchetti M; Donzelli C; Calza S; Ravaggi A; Bandiera E; Pecorelli S; Santin AD
Gynecol Oncol; 2007 Jun; 105(3):578-85. PubMed ID: 17343903
[TBL] [Abstract][Full Text] [Related]
40. The use of metabolomics for the discovery of new biomarkers of effect.
van Ravenzwaay B; Cunha GC; Leibold E; Looser R; Mellert W; Prokoudine A; Walk T; Wiemer J
Toxicol Lett; 2007 Jul; 172(1-2):21-8. PubMed ID: 17614222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
